Gitlab Inc vs Kenvue Inc. Common Stock — how do they compare? Gitlab Inc trades at $55.09 (market cap $8.92B), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is far larger — about 3.8× Gitlab Inc's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Gitlab Inc pays none. Which is the better fit depends on your goals.
| GTLB | KVUE | |
|---|---|---|
Market Cap | $8.92B | $34.06B |
Volume | 4,716,893 | 23,267,228 |
Sector | Technology | Consumer Staples |
52-Week High | $55.09 | $19.83 |
52-Week Low | $19.42 | $14.11 |
Typical Hold Time | 62 Days | — |
Enterprise Value | $7.66B | $41.56B |
Dividend Yield | — | 4.74% |
Signals from Pluang's Aura AI — not financial advice
GitLab (GTLB) trades at $53.56, up 3.02% today and near its 52-week high, with strong technical momentum indicated by moving averages. The company shows impressive revenue growth, reaching $759 million in 2025, but remains unprofitable with a negative net income margin of -4.99%. Recent Q2 2026 earnings beat expectations, and the stock surged on raised guidance and AI-driven demand optimism.
Outlook: GitLab benefits from AI integration in software development and strong sales momentum, but high valuation multiples (P/E 521) and persistent losses pose risks. Analyst consensus is mixed with a $49.71 price target below current levels, suggesting cautious optimism amid execution challenges and competitive pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Read more on GTLB →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →